▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

DistillerSR Launches Industry’s First Purpose-built GenAI Solution for Literature Reviews

DistillerSR Inc., the market leader in AI-enabled literature review software and creator of DistillerSR®, today announced the availability of Smart Evidence Extraction (SEE)™, the industry’s firs...

Business Wire

Smart Evidence Extraction (SEE) Accurately Finds, Suggests, Extracts, and Links Supporting Reference Evidence Instantly for Literature Reviews

BARCELONA, Spain: DistillerSR Inc., the market leader in AI-enabled literature review software and creator of DistillerSR®, today announced the availability of Smart Evidence Extraction (SEE)™, the industry’s first purpose-built GenAI solution for literature reviews. Depending on the subject matter, researchers generally take 2-3 hours to critically read and appraise a scientific journal’s findings, which, over the course of hundreds and thousands of references analyzed during a literature review, can lead to human fatigue and errors. With SEE, it now takes just a few seconds to extract and link the supporting evidence from scientific papers.

SEE is a composite AI technology, blending traditional AI and GenAI models. This approach addresses the information overload and context-noise issues faced by traditional GenAI models, providing faster, higher quality answer suggestions. Integrated into DistillerSR’s auditable workflow to ensure complete regulatory compliance and efficient human-in-loop oversight, SEE automatically extracts content to answer both closed and open-ended questions, including numerical content, sentiment analysis, risk of bias information and study summaries. SEE’s composite AI approach grounds the creativity of current GenAI models restricting response content to only the paper being reviewed.

“We’ve incorporated AI into the DistillerSR platform since 2016,” said Peter O’Blenis, CEO, DistillerSR Inc. “We view AI as part of our technology stack, integrated seamlessly within DistillerSR’s powerful workflow and evidence management platform, to dramatically accelerate the literature review process while still addressing the critical regulatory requirements of our customers. SEE is the next logical step in the evolution of AI in literature reviews.”

SEE incorporates comprehensive controls to manage copyright adherence, while ensuring that all data remains securely within the DistillerSR platform and is not shared with third-party GenAI vendors. In September of this year, DistillerSR adopted the NIST AI Risk Management Framework (RMF) to govern its AI models and third-party vendors. The framework allows customers and prospects to evaluate how the company governs the engineering, privacy, and ethical dimensions of newly developed AI features and their application to enhance health research.

Literature reviews are the cornerstone of evidence-based research; however, their production has traditionally been highly manual, time consuming, and error prone. In recent years, technology companies have attempted to apply large language models (LLMs) to extract and summarize scientific literature and clinical data. Most LLMs, however, generate significant inaccuracies, often called "hallucinations”, which can lead to serious data errors in regulatory submissions, scientific communications, and guideline development.

SEE provides researchers with a purpose-built GenAI solution that is integrated into an auditable and efficient human-in-the-loop literature review workflow. SEE’s proprietary technology grounds the creative nature of GenAI, making it more context aware and focused only on extracting data specific to the literature being reviewed.

From November 18-20th, DistillerSR will demonstrate SEE to ISPOR Europe conference attendees at booth 512. ISPOR is the Professional Society for Health Economics and Outcomes Research. The non-profit organization is the world’s largest professional society for health economics and outcomes research professionals.

Today, 80% of the world’s largest pharmaceutical and medical device companies trust DistillerSR to securely produce transparent, audit-ready, and regulatory compliant literature reviews. The DistillerSR platform and modular ecosystem enable our customers to securely automate the management and analysis of evidence-based research — faster, more accurately, more transparently, and at scale.

About DistillerSR Inc.
Visit www.distillersr.com.

® DistillerSR Inc. is a registered trademark of DistillerSR Inc.
™ Smart Evidence Extraction is a trademark of DistillerSR Inc.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Mutual of Omaha and Workday to Help Companies Enhance Employee Benefits…

Mutual of Omaha is excited to announce its relationship with Workday, Inc. to help employer-provided insurance customers improve their benefits programs…

Sei Labs Releases New “Giga” Roadmap That Will Bring 50x Improvement to…

Sei Labs, the main contributor to Sei, the fastest Layer 1 EVM blockchain, today announced its latest roadmap, dubbed “Giga”, charting its path to becoming…

Swoop Celebrates Triple Recognition in PM360’s 13th Annual Innovations…

PM360's 13th Annual Innovations Issue recognizes Swoop for its cutting-edge contributions to data-driven healthcare marketing. Honored with three prestigious…

Mastercard Finalizes Acquisition of Recorded Future

Mastercard (NYSE: MA) today completed its acquisition of Recorded Future. “As the world becomes more digitized, there's an increased focus on securing…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!